FDA accepts Telix brain cancer imaging drug application

Go back to FDA accepts Telix brain cancer imaging drug application
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.39 -0.05 (0.53%)
Previous Close $9.44    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.54    P/E N/A 
Day Low $9.34    EPS $-3.32 
Volume 65,525